Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN TYPE A Cause Hypoaesthesia? 703 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 703 reports of Hypoaesthesia have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 18.8% of all adverse event reports for BOTULINUM TOXIN TYPE A.

703
Reports of Hypoaesthesia with BOTULINUM TOXIN TYPE A
18.8%
of all BOTULINUM TOXIN TYPE A reports
541
Deaths
475
Hospitalizations

How Dangerous Is Hypoaesthesia From BOTULINUM TOXIN TYPE A?

Of the 703 reports, 541 (77.0%) resulted in death, 475 (67.6%) required hospitalization, and 468 (66.6%) were considered life-threatening.

Is Hypoaesthesia Listed in the Official Label?

Yes, Hypoaesthesia is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.

What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?

Off label use (1,785) Drug ineffective (1,175) Drug intolerance (1,004) Product use in unapproved indication (950) Headache (797) Migraine (775) Maternal exposure during pregnancy (716) Pain (714) Nausea (665) Gastrooesophageal reflux disease (660)

What Other Drugs Cause Hypoaesthesia?

ADALIMUMAB (7,423) ETANERCEPT (4,497) METHOTREXATE (4,175) RITUXIMAB (3,605) TOFACITINIB (3,324) PREDNISONE (3,239) TOCILIZUMAB (3,238) FINGOLIMOD (3,180) LENALIDOMIDE (3,127) SECUKINUMAB (3,079)

Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Hypoaesthesia Risk?

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE BOTULINUM TOXIN TYPE A vs BRENTUXIMAB BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN TYPE A vs BREO ELLIPTA BOTULINUM TOXIN TYPE A vs BREXANOLONE

Related Pages

BOTULINUM TOXIN TYPE A Full Profile All Hypoaesthesia Reports All Drugs Causing Hypoaesthesia BOTULINUM TOXIN TYPE A Demographics